Rigel Pharmaceuticals, Inc. (RIGL) is a clinical-stage drug development company that primarily is involved with innovation and development of small-molecule drugs which treat inflammatory and autoimmune disease, in addition to muscle disorders. RIGL is currently trading at approximately $2.68 in a 52 week range of $7.61 to $2.31.Year to date RIGL is underperforming the market by -91%, but over the last week has outperformed the market by 7.2%. Unusual options activity in RIGL in today’s trading session suggests that traders believe RIGL will continue higher through the beginning of the New Year. Earlier in today’s session a trader took part in a very bullish trade at 11.5 times normal volume. This is an extremely bullish trade with a high level of risk, meaning the trader’s conviction is relatively high. Although RIGL is currently trading below the cloud, the future cloud suggests the stock could trend higher in the short term.
Cheniere Energy Inc (LNG) is in the business of liquid natural gas, LNG. Cheniere Energy Inc. through subsidiaries develops liquefied natural gas terminals, and explores for oil and natural gas; primarily in the Gulf of Mexico. The company stock is currently trading at approximately $44.46. The 52 week range is $18.02 – $46.39. LNG has been outperforming the broader market this year by 107%. Last week LNG outperformed the market by 3.2%. Further, LNG is outperforming the Energy sector by 114%. The stock is still rising it appears, as the order flow has generally been bullish this quarter. LNG is currently trading above the cloud and suggests LNG could trend higher in the short term. As we continue to see bullish order flow and price action in LNG the stock continues higher.